Volume 4, Issue 3: Advances in Treating Hard-to-Treat Hepatitis C: Highlights from the American Association for the Study of Liver Diseases (AASLD) Meeting November 2015
e-Viral Hepatitis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with Hepatitis. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.
(Volume 4, Issue 3)
Nurses and health care professionals involved in the care of patients with Hepatitis.
After participating in this activity, the participant will demonstrate the ability to:
- Describe ongoing research into new therapies for patients with HCV genotype 3
- Evaluate the development of new agents and agent combinations to better manage hard-to-treat patients with HCV.
- Summarize real-world use of DAA therapies to manage HCV.
Mark S. Sulkowski, MD
Professor of Medicine
Medical Director, Viral Hepatitis Center
Divisions of Infectious Diseases and Gastroenterology/Hepatology
Johns Hopkins University School of Medicine
Stephanie Petrou Binder, MD
- 1.00 ANCC
- 1.00 Attendance